资讯 | 1药网赴美上市,拟融资2亿美元

wechat omage

美股

截至北京时间8月21日凌晨,美股周一收高,标普500指数逼近历史最高收盘纪录。美企并购交易大增,国际贸易关系有望取得进展,提振了市场情绪。

截止收盘,道指涨89.37点,或0.35%,报25,758.69点;标普500指数涨6.92点,或0.24%,报2,857.05点;纳指涨4.68点,或0.06%,报7,821.01点。

焦点股关注:

百事可乐(PEP)小幅收跌0.1%。该公司宣布将以32亿美元收购SodaStream International Ltd(SODA),相对后者上周五的收盘价,百事可乐的收购溢价率为11%。

泰森食品公司(TSN)宣布,将以21.6亿美元现金收购Keystone Foods。泰森食品收高1.6%。

雅诗兰黛(EL)宣布第四财季盈利及营收均超出预期,其股价收高3.4%。

Lannett(LCI)股价暴跌60.37%,此前该公司宣布其与Jerome Stevens Pharma的分销协议将不再续约。此外该公司还公布了低于市场预期的第四财季业绩展望。

特斯拉(TSLA)收高近1%。最近该公司CEO埃隆-马斯克(Elon Musk)出人意料地在推特上宣布准备将公司私有化的消息。另有报道称,沙特主权财富基金PIF正在与特斯拉公司的竞争对手Lucid Motors进行投资谈判。此前曾有报道称,马斯克曾希望获得PIF投资,以帮助他将特斯拉公司私有化。

1药网:两年亏损7.4亿 ,最高募资2亿美元

美国当地时间8月15日,1药网母公司111集团向美国证券交易委员会递交了招股书,最高募资2亿美元,交易代码为YI,承销商为摩根大通,花旗和中金。

1药网一直在做连接与生态,即去中间化,优化流程和运营,实现降本增效。这样一来,1药网形成了自营+平台、线上+线下、B端+C端、医+药结合的业务模式。

其招股说明书显示,公司在2016年和2017年分别实现收入8.74亿元和9.59亿元,净亏损分别为3.63亿元和2.49亿元。

另外招股说明书显示,此次公司最高募集资金2亿美元。111集团表示,此次募资主要有三个用途:一是用于研发,投资于人工智能、大数据等技术;二是用于营销以继续扩大客户群;三是用于满足战略收购投资、营运资金需求等一般企业目的。

公开资料显示,111集团注册于开曼群岛,由于刚、刘峻岭在2010年创建,前身为岗岭集团,于2018年5月正式更名。其官网资料显示,公司旗下目前拥有B2C医药平台“1药网”、互联网医院“1诊”、B2B医药平台“1药城”三大业务模块,其中,1药网的销售范围涵盖中西药品、滋补保健、医疗器械、药妆个护等数十万种医药健康产品。

   

港股

北京时间8月20日,周二开盘,恒生指数高开0.22%,之后腾讯强势反弹,推动恒指持续拉升。

截至收盘,恒生指数大涨1.41%,报27598.02点。国企指数涨1.13%,报10632.36点;红筹指数涨2.24%,报4126.9点。大市成交936.83亿港元。

沪港通资金流向方面,沪股通净流入40.1亿,港股通(沪)净流出为9.37亿。

深港通资金流向方面,深股通净流入18.4亿,港股通(深)净流入为3.54亿。

焦点股关注:
 
腾讯控股(0700)涨4.09%,报350.8元,领涨蓝筹。马化腾重回中国首富。在腾讯发布财报之后,大摩、富瑞、大和、摩通、野村等各大行纷纷调低目标价,不过仍然给予“买入”评级。

内房股上涨,中国恒大(3333)涨4.48%,报28元;融创中国(1918)涨3.25%,报23.85元;华润置地(1109)涨3.99%,报27.35元。

航空股集体上涨,中国东方航空(0670)涨6.56%,报4.71元;中国南方航空(1055)涨5.38%,报5.09元;中国国航(0753)涨4.2%,报6.7元。

 

中国A股

北京时间8月20日,沪指周一早盘高开,之后虽有金融股奋力护盘,但无奈市场整体走势疲软,逐渐震荡下行,随后钢铁、通信等板块大幅拉升,带动沪指回暖。

截止收盘,沪指报2698.47点,涨幅1.11%,成交1140.48亿元;深成指报8414.15点,涨幅0.68%,成交1506.95亿元。

从盘面上看,通信设备、高送转、租售同权、钢铁、券商等板块涨幅居前,二胎、猪肉、乳业、服装家纺、物流、环保等板块跌幅居前。

热点板块:

5G概念股快速拉升,中通国脉 (603559) 、奥士康 (002913) 、超讯通信 (603322) 等个股纷纷大涨。

租售同权概念股全天表现活跃,市北高新(600604)涨停,东易日盛(002713)、我爱我家(000560)、世联行(002285)纷纷大涨。消息面上,北京市住建委约谈住房租赁企业,明确不得恶性竞争抢占房源。

来源:东方财富网,新浪财经,同花顺,21世纪经济报道,彭博,华尔街见闻,辉立证券

联系我们开设账户

需要帮助吗?请分享您的详细资料,我们会给您答复。

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com